CD4+ T cells and later CD4 + Th1 cells are the most studied cell populations in MS [14] because of their potential role in the pathogenesis of the disease, as well as they are used to assess the effect of different therapies used in MS. The gene discussed is CD4; the disease is myeloid sarcoma.